FDA Drug Application (201966) for BUDESONIDE by SANDOZ INC

Back to FDA Applications sponsored by SANDOZ INC

Application Number201966
Product Number001
FormSUSPENSION;INHALATION
Dosage1MG/2ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AN Solutions and powders for aerosolization
Reference Drug
Drug NameBUDESONIDE
Active IngredientBUDESONIDE

Active IngredientCount
List of drugs with Active Ingredient BUDESONIDE9


Back to FDA Applications sponsored by SANDOZ INC